SCHEMBL7908800

SCHEMBL7908800

C/C(=N\OC(=O)c1ccccc1)NCCCC[C@H](N)C(=O)O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TNF P01375 1/20 0.41
KLF5 Q13887 1/20 0.41
NOD1 Q9Y239 1/20 0.41
NOS2 P35228 5/20 0.41
NOS1 P29475 4/20 0.41
NOS3 P29474 3/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
TSHR P16473 1/20 0.41
SLC7A5 Q01650 1/20 0.41
SMN1; SMN2 Q16637 2/20 0.40
BLM P54132 1/20 0.40
NPC1 O15118 3/20 0.40
RAB9A P51151 3/20 0.40
CDK5 Q00535 2/20 0.40
CDK5R1 Q15078 2/20 0.40
KMT2A Q03164 2/20 0.40
MAPT P10636 2/20 0.40
PKM P14618 1/20 0.40
POLB P06746 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7225511 1.00 TNF (0.41) TNFKLF5NOD1NOS2NOS1
Hydrochloric Acid SCHEMBL8205615 0.99 NOS2 (0.42) TNFKLF5NOD1NOS2NOS1
Hydrochloric Acid SCHEMBL8205619 0.99 NOS2 (0.42) TNFKLF5NOD1NOS2NOS1
SCHEMBL8223247 0.83 POLB (0.44) NOS2NOS1NOS3CYP1A2CYP3A4
SCHEMBL8223251 0.83 POLB (0.44) NOS2NOS1NOS3CYP1A2CYP3A4
SCHEMBL7911885 0.82 NOS2 (0.49) NOS2NOS1NOS3CYP1A2CYP3A4
SCHEMBL7226879 0.82 NOS2 (0.49) NOS2NOS1NOS3CYP1A2CYP3A4
SCHEMBL7909528 0.81 NOS2 (0.48) NOS2NOS1NOS3CYP1A2CYP3A4
SCHEMBL7224528 0.81 NOS2 (0.48) NOS2NOS1NOS3CYP1A2CYP3A4
SCHEMBL7226863 0.79 NOS2 (0.46) NOS2NOS1NOS3CYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6207708-B1 FOR THERAPY AND PROPHYLAXIS OF AUTOIMMUNE AND/OR INFLAMMATORY CONDITIONS AFFECTING THE JOINTS SUCH AS ARTHRITIS, AND INFLAMMATORY BOWEL DISEASE, CARDIVASCULAR ISCHEMIA, DIABETES, CONGESTIVE HEART FAILURE, MYOCARDITIS, ATHEROSCLEROSIS, G. D. SEARLE & COMPANY 2001-03-27 US claimed
EP-0885188-B1 HYDROXYAMIDINO DERIVATIVES USEFUL AS NITRIC OXIDE SYNTHASE INHIBITORS SEARLE & CO (US) 2000-09-27 EP claimed
WO-1997032844-A9 HYDROXYAMIDINO DERIVATIVES USEFUL AS NITRIC OXIDE SYNTHASE INHIBITORS 1997-12-24 WO claimed